Clinical Trials Logo

Dysmenorrhea clinical trials

View clinical trials related to Dysmenorrhea.

Filter by:

NCT ID: NCT03608215 Completed - Clinical trials for Primary Dysmenorrhea

Neuromodulatary Efficacy of Transcranial Direct Current Stimulation in Severe Refractory Primary Dysmenorrhea

Start date: September 8, 2015
Phase: N/A
Study type: Interventional

Primary Dysmenorrhea (PDM), defined as menstrual pain without discernable organic causes, is inexorably common in adolescent women, about 40-90% of women may suffer from it, and 20% of them can be severe in the context of being refractory to medication, daily function impairment, and having pain of severe degree. Novel therapeutic method is in need for pain alleviation for this particular phenotype. It has been reported that PDM females may engage motor-cortex based descending pain modulation system in our resting-state functional Magnetic Resonance Imaging (rs-fMRI) and thermal pain-activation fMRI studies. Based on the reported analgesic efficacy of transcranial Direct Current Stimulation (tDCS) on the motor cortex for various experimental painful conditions and clinical pain disorders, it is plausible that tDCS can be effective for the severe and medication-refractory PDM patients. This study aim to investigate the analgesic efficacy of tDCS in severe PDMs and to elucidate the dynamic brain neuroplasticity in the context of experimental pain after tDCS intervention. Thirty severe PDMs will be recruited and randomly allocated to either real or sham group in a triple-blind manner. Experimental pain electrical stimulation will be performed before and after the tDCS intervention. The experimental pain-evoked magnetoencephamographic (MEG) data will be correlated with behavioral and psychological measurements. This is the first study in the literature investigating the tDCS efficacy for acute pain in severe PDM. The result can promise a new possibility for clinical application.

NCT ID: NCT03594916 Completed - Clinical trials for Primary Dysmenorrhea

Efficacy of Transcranial Direct Current Stimulation for Severe Primary Dysmenorrhea

Start date: September 8, 2015
Phase: N/A
Study type: Interventional

Primary Dysmenorrhea (PDM), defined as menstrual pain without discernable organic causes, is inexorably common in adolescent women, about 40-90% of women may suffer from it, and 20% of them can be severe in the context of being refractory to medication, daily function impairment, and having pain of severe degree. Novel therapeutic method is in need for pain alleviation for this particular phenotype. We have previously reported that PDM females may engage motor-cortex based descending pain modulation system in our resting-state functional Magnetic Resonance Imaging (rs-fMRI) and thermal pain-activation fMRI studies. Based on the reported analgesic efficacy of transcranial Direct Current Stimulation (tDCS) on the motor cortex for various experimental painful conditions and clinical pain disorders, we reason that tDCS can be effective for the severe and medication-refractory PDM patients. This study aim to investigate the analgesic efficacy of tDCS in severe PDMs and to elucidate the dynamic brain neuroplasticity in the context of functional connectivity (FC) of pain matrix after tDCS intervention. We will recruit 30 severe PDMs and randomly allocate them to either real or sham group in a triple-blind manner. rs-fMRI for functional connectivity analysis will be performed before and after the tDCS intervention. The imaging data will be correlated with behavioral and psychological measurements. This is the first study in the literature investigating the tDCS efficacy for severe PDM. The result can promise a new possibility for clinical application.

NCT ID: NCT03593850 Completed - Clinical trials for Primary Dysmenorrhea

Music for Pain in Primary Dysmenorrhea

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). This two forms of treatment have not demonstrated 100% efficacy, and adverse events and contraindications for both exist. Moreover, studies have demonstrated that an important women do not use, or don't like to use, pharmacological treatment. Music have demonstrated analgesic effects in different clinical contexts, and has emerged as an important form of complementary therapy in the management of pain. To the researcher's knowledge, no studies have been conducted to evaluate music's effectiveness in pain secondary to primary dysmenorrhea. The following is the protocol for a randomized, single blinded, clinical trial, where an experimental group listened to a 30 minute song, and was compared to a control group that rest in silence for the same time and conditions. It was expected that music will produce a larger, and significant, effect on pain reduction when compared to the control silence group according to pain measured through a 10 cm Visual Analogue Scale (VAS) in young women from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogota DC, Colombia. Additionally, the investigators wanted to evaluate the clinical effect of music and analgesic requirements, anxiety and vital signs were also measured.

NCT ID: NCT03593057 Completed - Clinical trials for Dysmenorrhea Primary

Effectiveness of Manual Therapy in Dysmenorrhea

MTDysmen
Start date: June 5, 2018
Phase: N/A
Study type: Interventional

The objective of this clinical study would be to verify if manual therapy is effective in the treatment to reduce pain in women suffering from primary dysmenorrhea. Material and methods In this experimental study, women diagnosed with primary dysmenorrhea will be included, which will be divided randomly into two groups: an intervention group and a comparator group. The study will last nine weeks (3 menstrual cycles). Patients in the intervention group will receive 3 treatment sessions. The evaluation will include pain, the quality of life, the global impression of change, personal body satisfaction and global self-perception and the pain perception.

NCT ID: NCT03509740 Completed - Dysmenorrhea Clinical Trials

Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea

Start date: April 25, 2018
Phase: Phase 4
Study type: Interventional

Patients presented with primary dysmenorrhea composed the study population. One gram paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in ceasing dysmenorrhea in the emergency department

NCT ID: NCT03448536 Completed - Dysmenorrhea Clinical Trials

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Start date: April 5, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the maximum single dose of Aleve® (two tablets, equivalent to 440 mg of naproxen sodium) to the maximum single dose of Tylenol Extra Strength (two caplets, equivalent to 1000 mg of acetaminophen) in the treatment of menstrual pain associated with primary dysmenorrhea.

NCT ID: NCT03446859 Completed - Clinical trials for Primary Dysmenorrhea

TENS on Pain Intensity in Primary Dysmenorrhea

TENSinPain
Start date: August 4, 2017
Phase: N/A
Study type: Interventional

Dysmenorrhoea is a common problem in women of reproductive age. It is associated with painful uterine contractions and discomfort. The primary aim of the study was to determine the effect of Transcutaneous Electrical Nerve Stimulation (TENS) on pain intensity associated with primary dysmenorrhoea among female undergraduate students of Obafemi Awolowo University. The study involved 50 females undergraduates of Obafemi Awolowo University with primary dysmenorrhoea lasting for at least 5 days. They were allocated in to two groups equally. One group was treated with TENS and other group served as control. The treatment was for 5 days and Pain intensity was measured before and after the treatment in the two groups. The post treatment pain intensity was then compared.

NCT ID: NCT03323671 Completed - Clinical trials for Primary Dysmenorrhea

Preemptive Analgesia for Primary Dysmenorrhoea

Start date: August 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Preemptive analgesia before the release of pain mediators

NCT ID: NCT03290066 Completed - Clinical trials for Primary Dysmenorrhea

Effectiveness of Kinesiotaping in Primary Dysmenorrhea

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Determine the effectiveness of kinesiotaping on pain in primary dysmenorrhea.

NCT ID: NCT03269591 Completed - Dysmenorrhea Clinical Trials

Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea

magnetic
Start date: February 1, 2016
Phase: N/A
Study type: Interventional

Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women